With this study, we aimed to describe the evolution of the clinical characteristics and HRQoL of SCN1A-related seizure disorders over time, by a cross-sectional exploration and analysis of disease features and HRQoL per age group, and by a follow-up of HRQoL and disease features within individual patients measured at two timepoints 7 years apart. This evidence concerns the gene SCN1A and epilepsy.